EcoDrugPlus

Cathepsin S

Ensembl ID : ENSPEMG00000009697
Gene Symbol: CTSS
3 Cross references
269 Possible Orthologues:

Cell Division Cycle 7 (S. Cerevisiae)

Ensembl ID : ENSPEMG00000022245
Gene Symbol: CDC7
1 Cross references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSPEMG00000021881
Gene Symbol: CHEK1
1 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSPEMG00000012801
Gene Symbol: CHEK2
3 Cross references
204 Possible Orthologues:

Chemokine (C-C Motif) Receptor 4

Ensembl ID : ENSPEMG00000019665
Gene Symbol: CCR4
1 Cross references
254 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 2

Ensembl ID : ENSPEMG00000029924
Gene Symbol: CXCR2
1 Cross references
237 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSPEMG00000025192
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSPEMG00000028494
Gene Symbol: CCKBR
3 Cross references
264 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSPEMG00000013265
Gene Symbol: LOC102908607
3 Cross references
259 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSPEMG00000027279
Gene Symbol: CHRM1
3 Cross references
101 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSPEMG00000024536
Gene Symbol: CHRM2
3 Cross references
259 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSPEMG00000006154
Gene Symbol: CHRM3
3 Cross references
255 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).